ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 655105 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 655105; 2) Community: the network communities that were significantly associated with the response to NSC 655105; 3) Molecule: the relationships between components within communities and NSC 655105; 4) MDR: the compounds that were significantly associated with the NSC 655105.

NSC Compound Enrichment Correlation
NSC 683564 2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, methyl ester, (Z,E)- 0.00396536695012845 0.84605023
NSC 692587 ethyl-8-(4-chlorophenyl)-4-methyl-2-oxo-6-(thiophen-2-yl)-4a,7-dihydro-2H-chromene-3- carboxylate 0.00396536695012845 0.47561155
NSC 716679 Null 0.00396536695012845 0.51800245
NSC 625498 4-Morpholinecarbodithioic acid, antimony complex 0.00526022686151163 0.51346873
NSC 651590 ANTINEOPLASTIC-651590 0.00526022686151163 0.77498423
NSC 699671 Null 0.00526022686151165 0.81116165
NSC 715572 Null 0.00526022686151165 0.60809415
NSC 749147 Null 0.00526022686151165 0.68752647
NSC 135077 BERSALDEGENIN 1,3,5-ORTHOACETATE 0.00578566967432525 0.38807295
NSC 163664 Arsinothious acid, dimethyl-, 2,4-pyrimidinediyl ester (9CI) 0.00578566967432525 0.60838055
Total:112  Current:28    [First] [Prev] [Next] [Last]